A TaqI RFLP in the human ret proto-oncogene. 1990

T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002879 Chromosomes, Human, Pair 10 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 10
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1
D015252 Deoxyribonucleases, Type II Site-Specific Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4. DNA Restriction Enzymes, Type II,DNase, Site-Specific, Type II,Restriction Endonucleases, Type II,Type II Restriction Enzymes,DNase, Site Specific, Type II,Deoxyribonucleases, Type II, Site Specific,Deoxyribonucleases, Type II, Site-Specific,Site-Specific DNase, Type II,Type II Site Specific DNase,Type II Site Specific Deoxyribonucleases,Type II Site-Specific DNase,Type II Site-Specific Deoxyribonucleases,Deoxyribonucleases, Type II Site Specific,Site Specific DNase, Type II

Related Publications

T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
August 1990, Nihon rinsho. Japanese journal of clinical medicine,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
November 2000, Oncogene,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
May 1988, Nucleic acids research,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
April 1990, Japanese journal of cancer research : Gann,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
January 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
December 1998, American journal of medical genetics,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
November 1995, Oncogene,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
December 1989, Oncogene,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
March 1997, Nagoya journal of medical science,
T Tahira, and M Shiraishi, and Y Ishizaka, and I Ikeda, and R Sakai, and T Sugimura, and M Nagao
October 1995, Journal of internal medicine,
Copied contents to your clipboard!